Chemed (CHE) EPS (Basic) (2009 - 2026)

Chemed (CHE) has reported EPS (Basic) for 18 consecutive years, with $1.76 the latest figure, recorded in Q1 2026.

• In Q1 2026, EPS (Basic) fell 7.78% year-over-year to $1.76; the TTM figure through Mar 2026 stood at $9.3 (up 13.12% YoY), while the FY2025 annual figure was $9.45, up 17.13% from the prior year.
• EPS (Basic) came in at $1.76 for Q1 2026 at Chemed, down from $4.44 in the prior quarter.
• The five-year high for EPS (Basic) was $4.44 in Q4 2025, with the low at $1.4 in Q2 2025.
• Average EPS (Basic) over 5 years is $1.97, with a median of $1.76 recorded in 2026.
• The largest YoY upside for EPS (Basic) was 83.92% in 2025 against a maximum downside of 26.5% in 2025.
• Year by year, EPS (Basic) stood at $1.69 in 2022, then jumped by 47.46% to $2.49 in 2023, then declined by 3.06% to $2.41 in 2024, then surged by 83.92% to $4.44 in 2025, then sank by 60.28% to $1.76 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered $1.76, $4.44, and $1.71 for Q1 2026, Q4 2025, and Q3 2025 respectively.